AMMF Grants for Research

Grants for Research
  • Imperial College London
  • University College London
  • The Institute of Hepatology London
  • University of Birmingham
  • University of Cambridge
  • University of Edinburgh
  • University of Nottingham
  • University of East Anglia
  • University of Manchester
  • University of Liverpool
  • University of Oxford
  • University of Leeds
  • Cardiff University
  • Universities of Madrid, Navarra and Pamplona, Spain
  • John Hopkins University, USA
  • Sapienza University of Rome
  • University of Copenhagen
  • University of Glasgow

AMMF welcomes funding applications from research bodies for cholangiocarcinoma work. For more information, click here


University of Liverpool

Mr Marc Quinn

Award: £25,000

Awarded in 2023 to be given over 2 years, to support work investigating, “Unravelling intra-tumoral heterogeneity in cholangiocarcinoma through single cell RNA sequencing”.

Ref 2023/217

Mr Marc Quinn

University of Oxford

Dr Shijie Cai

Award £56,002.57

Awarded in 2023 for 1-year postdoctoral salary, to support work investigating “Normal cholangiocyte containment of cholangiocarcinoma through metabolic and transcriptomic regulation”.

Ref 2023/219




University of Glasgow

Professor Chiara Braconi

Award £99,464.00

Awarded in 2023 to be given over 2 years, to support work investigating “Identifying therapeutic opportunities for Biliary Cancers by investigating the role of Monocytes in drug response”.

Ref 2023/218




University of Edinburgh

Dr Ed Jarman and Dr Paula Olaizola

Award £50,000.00

Awarded in 2023 to be given over 3 years, to support work investigating “Does retinol from hepatic stellate cells fuel tumour cells during cholangiocarcinoma initiation”.

Ref 2023/221




Sapienza University of Rome

Professor Carmine Mancone

Award: £35,000.00

Awarded in 2022 to be given over 2 years, to support work investigating “The role of THBS1, THBS2 and PEDF in the lymphatic dissemination of the intrahepatic cholangiocarcinoma: identification of downstream signalling pathway”.

Ref 2022/211




University of Copenhagen

Professor Jesper Andersen

Award: £45,339.00

Awarded in 2022 to support work investigating “Tumour phenotypes and sensitivities triggered by IL-6 activation in intrahepatic cholangiocarcinoma”.

Ref 2022/212


University of Manchester

Dr Alicia-Marie Conway

Award: £30,850.00

Awarded in 2022 to support work investigating “Intrahepatic cholangiocarcinoma hidden amongst the Unknown: biomarker discovery and novel diagnostic approach from circulation: Free DNA (cfDNA) in cancers of unknown primary”.

Ref 2022/216


Imperial College London

Micol Damiani

Award: £27,625.78

Awarded in 2022 to support work investigating “Single-molecule multiplexed detection of biomarkers for HCC and CCA using a novel nanopore – based sensing.”

Ref 2022/213


University of Nottingham

Professor Kevin Gaston

Award: £24,250.00

Awarded in 2022 to support work investigating “Ultra high-resolution mapping of spatial patterns of gene and protein expression in cholangiocarcinoma and the cholangiocarcinoma tumour microenvironment”.

Ref 2022/214


University of Nottingham

Professor Sheela Jayaraman

Award: £22,000.00

Awarded in 2022 to support work investigating “Combination therapies for Cholangiocarcinoma”.

Ref 2022/215


University of Nottingham

Dr Isioma Egbuniwe

Award: £28,750.20

Awarded in 2020 to be given over 2 years, to support work investigating “The role of Interleukin 17 (IL-17) in tumour lymphangiogenesis in cholangiocarcinoma”.

Ref 2020/210


University of Nottingham

Professor Sheela Jayaraman

Award: £19,260

Awarded in 2019 to be given over 3 years, to support work investigating, “New strategies for the inhibition of Cholangiocarcinoma tumour growth”.

Ref 2019/204


Recently Completed Grants

For information on some of the recently completed AMMF awards for research, click here


AMMF Research Grants – Applications

One of AMMF’s major objectives is to support specialised research teams in their work to find the causes, methods of earlier diagnosis, and effective treatments for cholangiocarcinoma (CC). AMMF welcomes funding applications from research bodies for cholangiocarcinoma work.  For more details, and how to apply for funding, please click here

August 2024